These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 2898508

  • 21. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
    Cuomo L, Trivedi P, Wang F, Winberg G, Klein G, Masucci MG.
    Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
    [Abstract] [Full Text] [Related]

  • 22. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
    Murray RJ, Young LS, Calender A, Gregory CD, Rowe M, Lenoir GM, Rickinson AB.
    J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
    [Abstract] [Full Text] [Related]

  • 23. The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition.
    Makgoba MW, Sanders ME, Shaw S.
    Immunol Today; 1989 Dec; 10(12):417-22. PubMed ID: 2482743
    [Abstract] [Full Text] [Related]

  • 24. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
    Galocha B, López D, López de Castro JA.
    J Immunol; 1993 Mar 01; 150(5):1653-62. PubMed ID: 7679690
    [Abstract] [Full Text] [Related]

  • 25. Expression of Epstein-Barr virus latent genes and adhesion molecules in AIDS-related non-Hodgkin's lymphomas: correlation with histology and CD4-cell number.
    Kersten MJ, Van Gorp J, Pals ST, Boon F, Van Oers MH.
    Leuk Lymphoma; 1998 Aug 01; 30(5-6):515-24. PubMed ID: 9711914
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Isolation of a normal B cell subset with a Burkitt-like phenotype and transformation in vitro with Epstein-Barr virus.
    Gregory CD, Edwards CF, Milner A, Wiels J, Lipinski M, Rowe M, Tursz T, Rickinson AB.
    Int J Cancer; 1988 Aug 15; 42(2):213-20. PubMed ID: 2841246
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice.
    Walter J, Möller P, Moldenhauer G, Schirrmacher V, Pawlita M, Wolf J.
    Int J Cancer; 1992 Jan 21; 50(2):265-73. PubMed ID: 1309726
    [Abstract] [Full Text] [Related]

  • 30. Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma.
    Rooney CM, Rickinson AB, Moss DJ, Lenoir GM, Epstein MA.
    IARC Sci Publ; 1985 Jan 21; (60):249-64. PubMed ID: 2998992
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Lymphokine-activated killer (LAK) cells discriminate between Epstein-Barr virus (EBV)-positive Burkitt's lymphoma cells.
    Misko IS, Schmidt C, Martin N, Moss DJ, Sculley TB, Burrows S, Burman KJ.
    Int J Cancer; 1990 Sep 15; 46(3):399-404. PubMed ID: 2168343
    [Abstract] [Full Text] [Related]

  • 34. A monoclonal antibody to LFA-3, the CD2 ligand, specifically immobilizes major histocompatibility complex proteins.
    Bierer BE, Golan DE, Brown CS, Herrmann SH, Burakoff SJ.
    Eur J Immunol; 1989 Apr 15; 19(4):661-5. PubMed ID: 2471647
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
    Gavioli R, De Campos-Lima PO, Kurilla MG, Kieff E, Klein G, Masucci MG.
    Proc Natl Acad Sci U S A; 1992 Jul 01; 89(13):5862-6. PubMed ID: 1321426
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones.
    Shaw S, Luce GE, Quinones R, Gress RE, Springer TA, Sanders ME.
    Nature; 1992 Jul 01; 323(6085):262-4. PubMed ID: 3093887
    [Abstract] [Full Text] [Related]

  • 40. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.
    Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB.
    EMBO J; 1987 Sep 01; 6(9):2743-51. PubMed ID: 2824192
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.